Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Mesothelioma, Malignant × ascrinvacumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 1

Interventions

Cisplatin 4 Pemetrexed 3 Gemcitabine 2 Bortezomib 2 raltitrexed 1 nintedanib 1 ascrinvacumab 1 Radiotherapy 1 Neoadjuvant Therapy 1 Chemotherapy, Adjuvant 1 Cerebral Decortication 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01486368 2023-08-04

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Canadian Cancer Trials Group

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡